These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2114788)

  • 21. Acute myocardial infarction treatments in 58 Italian hospitals: a drug utilization survey.
    Venturini F; Romero M; Tognoni G
    Ann Pharmacother; 1995 Nov; 29(11):1100-5. PubMed ID: 8573952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.
    de Bono DP; Simoons ML; Tijssen J; Arnold AE; Betriu A; Burgersdijk C; López Bescos L; Mueller E; Pfisterer M; Van de Werf F
    Br Heart J; 1992 Feb; 67(2):122-8. PubMed ID: 1540431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retreatment with alteplase for early signs of reocclusion after thrombolysis. The European Cooperative Study Group.
    Simoons ML; Arnout J; van den Brand M; Nÿssen K; Verstraete M
    Am J Cardiol; 1993 Mar; 71(7):524-8. PubMed ID: 8438737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ridogrel does not increase the speed and rate of coronary recanalization in patients with myocardial infarction treated with alteplase and heparin.
    Tranchesi B; Pileggi F; Vercammen E; Van de Werf F; Verstraete M
    Eur Heart J; 1994 May; 15(5):660-4. PubMed ID: 8056007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction.
    Tranchesi B; Chamone DF; Cobbaert C; Van de Werf F; Vanhove P; Verstraete M
    Am J Cardiol; 1991 Jul; 68(2):161-5. PubMed ID: 1829574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argatroban and alteplase in patients with acute myocardial infarction: the ARGAMI Study.
    Vermeer F; Vahanian A; Fels PW; Besse P; Müller E; Van de Werf F; Fitzgerald D; Darius H; Puel J; Garrigou D; Simoons ML;
    J Thromb Thrombolysis; 2000 Dec; 10(3):233-40. PubMed ID: 11122543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Off-target effects of thrombolytic drugs: apolipoprotein A-I proteolysis by alteplase and tenecteplase.
    Gomaraschi M; Ossoli A; Vitali C; Pozzi S; Vitali Serdoz L; Pitzorno C; Sinagra G; Franceschini G; Calabresi L
    Biochem Pharmacol; 2013 Feb; 85(4):525-30. PubMed ID: 23219857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarction.
    Binbrek AS; Rao NS; Neimane D; Hatou E; Abdulali S; Sobel BE
    Am J Cardiol; 2004 Jun; 93(12):1465-8. PubMed ID: 15194014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis.
    Wilcox RG; von der Lippe G; Olsson CG; Jensen G; Skene AM; Hampton JR
    Lancet; 1990 May; 335(8699):1175-8. PubMed ID: 1971034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Haematoma of the floor of the mouth associated to acute myocardial infarction].
    Pelaz A; Bayón J; Gallego L; Junquera L
    Acta Otorrinolaringol Esp; 2011; 62(6):462-4. PubMed ID: 21163462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) in suspected acute myocardial infarction.
    Wilcox RG; Eastgate J; Harrison E; Skene AM
    Br Heart J; 1991 Jan; 65(1):4-8. PubMed ID: 1899582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.
    Dalla-Volta S; Palla A; Santolicandro A; Giuntini C; Pengo V; Visioli O; Zonzin P; Zanuttini D; Barbaresi F; Agnelli G
    J Am Coll Cardiol; 1992 Sep; 20(3):520-6. PubMed ID: 1512328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of myocardial ischemia six months after thrombolytic treatment of acute coronary episodes. A subset of a placebo controlled, randomised trial, the ASSET Study.
    Vaage-Nilsen M; Aurup P; Høegholm A; Eidemark I; Rasmussen V; Jensen G
    Int J Cardiol; 1993 Jun; 39(3):187-93. PubMed ID: 8101512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of early intravenous heparin on coronary patency infarct size, and bleeding complications after alteplase thrombolysis.
    Massel DR
    Br Heart J; 1992 Sep; 68(3):342. PubMed ID: 1389772
    [No Abstract]   [Full Text] [Related]  

  • 35. A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.
    Gemmill JD; Hogg KJ; MacIntyre PD; Booth N; Rae AP; Dunn FG; Hillis WS
    Br Heart J; 1991 Aug; 66(2):134-8. PubMed ID: 1909151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind randomized trial of alteplase versus placebo in patients with chest pain at rest.
    Roberts MJ; McNeill AJ; Dalzell GW; Wilson CM; Webb SW; Khan MM; Patterson GC; Adgey AA
    Eur Heart J; 1993 Nov; 14(11):1536-42. PubMed ID: 8299637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community hospital experience with recombinant tissue plasminogen activator in acute myocardial infarction.
    Austin SM; Caro M; Gemmel D
    J Gen Intern Med; 1992; 7(2):187-90. PubMed ID: 1487767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue plasminogen activator: hospital experience.
    LiMandri G; Dunn D; Burd C; Gregory J
    N J Med; 1991 Aug; 88(8):561-5. PubMed ID: 1922986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug interaction monitoring program in a community hospital.
    Cramer RL; Sketo DV; Greene JL; Wright CA
    Am J Hosp Pharm; 1992 Mar; 49(3):627-9. PubMed ID: 1598942
    [No Abstract]   [Full Text] [Related]  

  • 40. Bleeding complications following initiation of thrombolytic therapy for acute myocardial infarction: a comparison of helicopter-transported and nontransported patients.
    Fromm RE; Hoskins E; Cronin L; Pratt CM; Spencer WH; Roberts R
    Ann Emerg Med; 1991 Aug; 20(8):892-5. PubMed ID: 1906690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.